The pathogenic bacterium Staphylococcus aureus is the most common pathogen isolated in
skin-and-soft-tissue infections (SSTIs) in the United States. Most S. aureus SSTIs are caused …

Since antibiotic resistance usually affords a gain of function, there is an associated
biological cost resulting in a loss of fitness of the bacterial host. Considering that antibiotic …

The widespread use of antibiotics in association with high-density clinical care has driven
the emergence of drug-resistant bacteria that are adapted to thrive in hospitalized patients …

These evidence-based guidelines have been produced after a literature review of the
treatment and prophylaxis of methicillin-resistant Staphylococcus aureus (MRSA) infection …

A pathogenic vancomycin-resistant Staphylococcus aureus (VRSA) isolate (MIC≥ 64 μg
ml− 1) was obtained from a Kolkata hospital in June 2005. Species identification was …

Introduction: The resistance to antimicrobial agents among Staphylococci is an increasing
problem. This has led to renewed interest in the usage of Macrolide-Lincosamide …

Methicillin-resistant Staphylococcus aureus (MRSA) has long been a common pathogen in
healthcare facilities, but in the past decade, it has emerged as a problematic pathogen in the …

Abstract Background Antimicrobial resistance of Staphylococcus aureus especially
methicillin-resistant S. aureus (MRSA) continues to be a problem for clinicians worldwide …

Purpose: Clindamycin is commonly used in the treatment of erythromycin resistant
Staphylococcus aureus causing skin and soft tissue infections. In vitro routine tests for …

Background Staphylococcus aureus, an important nosocomial pathogen, is frequently
associated with infections in human. The management of the infections by it especially …